Iron Supplementation in IDA with Positive FIT
Rationale for Immediate Iron Therapy
- The British Society of Gastroenterology recommends that iron replacement therapy should not be deferred while awaiting investigations for IDA unless colonoscopy is imminent, with high-quality evidence and 100% consensus 1, 2
- Iron therapy does not interfere with future gastrointestinal investigations, including endoscopy and histopathology, according to the British Society of Gastroenterology 1, 2
Recommended Iron Dosing Regimen
- The British Society of Gastroenterology recommends starting with ferrous fumarate 200 mg once daily, containing approximately 65 mg elemental iron, for iron supplementation in IDA 1, 2
- Once-daily dosing achieves similar total iron absorption as multiple daily doses, based on hepcidin physiology 2
Investigation Timeline with Positive FIT
- The British Society of Gastroenterology guidelines recommend that colonoscopy should be performed within 3 months, and absolutely within 6 months, of a positive FIT 3
- Delays beyond 6 months are associated with higher risks of advanced adenomas, colorectal cancer, and advanced-stage disease 3
Monitoring and Duration of Therapy
- The British Society of Gastroenterology recommends checking hemoglobin response at 4 weeks, expecting a rise of approximately 2 g/dL if compliant and no ongoing bleeding 1, 4
- Iron therapy should be continued for 3 months after hemoglobin normalization to replenish bone marrow iron stores, as recommended by the British Society of Gastroenterology 1, 5, 2, 4
Critical Next Steps
- The British Society of Gastroenterology guidelines recommend prescribing ferrous fumarate 200 mg once daily immediately, and arranging urgent gastroscopy and colonoscopy within 3 months maximum 1, 2, 3
- Screening for celiac disease with tissue transglutaminase antibodies and IgA level, or obtaining duodenal biopsies at gastroscopy, is also recommended by the British Society of Gastroenterology 1
Monitoring Iron Levels During Ferrous Fumarate Therapy
Ongoing Monitoring Schedule
- The National Kidney Foundation recommends evaluating iron status parameters, such as transferrin saturation and ferritin, at least every 3 months during continued iron supplementation therapy, particularly in patients requiring prolonged treatment or those with chronic conditions causing iron deficiency 6
- More frequent monitoring is indicated when initiating or increasing iron dosage, as suggested by the Kidney International guidelines 6
- The Kidney International guidelines also recommend more frequent monitoring when active blood loss is present or suspected, when monitoring response after switching from oral to IV iron, or when clinical circumstances suggest iron store depletion 6
- Baseline iron parameters, including hemoglobin, ferritin, and transferrin saturation, should be checked before starting ferrous fumarate therapy, according to the Kidney International guidelines 6
- The Kidney International guidelines suggest checking hemoglobin, ferritin, and transferrin saturation at month 3, and every 3 months thereafter, until 3 months post-normalization 6